IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,980,509 | -35.4% | 655,057 | 0.0% | 0.33% | +2.8% |
| Q2 2023 | $4,611,601 | +15.2% | 655,057 | 0.0% | 0.32% | +14.4% |
| Q1 2023 | $4,002,398 | +95513.9% | 655,057 | 0.0% | 0.28% | -42.3% |
| Q4 2022 | $4,186 | -99.9% | 655,057 | 0.0% | 0.48% | -30.4% |
| Q3 2022 | $6,275,000 | -13.2% | 655,057 | 0.0% | 0.69% | -4.5% |
| Q2 2022 | $7,232,000 | -33.7% | 655,057 | 0.0% | 0.73% | -3.3% |
| Q1 2022 | $10,907,000 | +89.8% | 655,057 | +117.6% | 0.75% | +117.1% |
| Q4 2021 | $5,746,000 | -85.4% | 301,000 | -81.2% | 0.35% | -90.6% |
| Q2 2019 | $39,232,000 | +157.8% | 1,600,000 | 0.0% | 3.68% | +142.3% |
| Q1 2019 | $15,216,000 | +7.5% | 1,600,000 | 0.0% | 1.52% | -16.1% |
| Q4 2018 | $14,160,000 | – | 1,600,000 | – | 1.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |